The stromal interaction molecules STIM1 and STIM2 are 
Introduction

Calcium is a ubiquitous intracellular signalling molecule implicated in the control of an impressive variety of cell behaviours, from immediate responses such as contraction and secretion, to longer-term responses including proliferation, differentiation and apoptosis. Consequently, it is not surprising that deregulation of Ca
2ϩ signalling is a feature of multiple diseases [1] [2] [3] and several aspects of Ca 2ϩ signalling regulation have been successfully targeted therapeutically [4, 5] . The maintenance of intracellular Ca 2ϩ concentration ([Ca 2ϩ ]i) at around 100 nM, at least 10,000-fold lower than the Ca 2ϩ concentration in the extracellular milieu [6] , is key to these ions' ability to act as a second messenger. A rise in [Ca 2ϩ ]i mediated by cell surface signalling molecules can be rapidly detected, decoded by the cell and translated into an appropriate cellular response. In many cells, receptor stimulation [17, 19, 20] . Therefore, in this review, we focus on the cell and molecular mechanisms by which STIM proteins control developmental processes and cell function, with a particular focus on studies that shed light on the functional differences between STIM1 and STIM2 in cell physiology. [46] . SOCE also increases during myoblast differentiation concomitant with an increase in the expression of STIM1 and ORAI1 [47, 48] . However, the transcriptional and translational regulation of STIM1 has received little attention thus far.
Part I: STIM proteins STIM1 and SOCE
The function of STIM1 in SOCE is 2-fold -(i) to
STIM1 and the regulation of other proteins at the plasma membrane
A proportion (possibly 15-30%, [49] [56, 57] [60, [64] [65] [66] [67] . In SCID patients bearing mutations in ORAI1, nuclear extracts from T cells contain virtually no NFAT binding activity, implicating this transcription factor as a key mediator of the disease [68] . [68] . Calcineurin-mediated nuclear import is balanced by nuclear export, involving nuclear kinases such as GSK3␤, casein kinase I and DYRK1A that rephosphorylate NFAT [70] homeostasis [63] . No gross neurological deficits or structural abnormalities were visible in STIM2-deficient mice, suggesting that reduced SOCE does not influence brain development in a major way [63] . However, a pronounced cognitive impairment became apparent when mice were tested for hippocampus-dependent spatial memory using the Morris water maze test [63] [116] . An increased resting [Ca 2ϩ ]i is characteristic of adipocytes from overweight human beings and rodents, which develops in as little as 3 weeks following initiation of a high fat diet in rats [117] [118] [119] [120] . Manoeuvres which reduce these high [Ca 2ϩ ]i can reverse weight gain, and improve insulin responses [121, 122] [123, 124] , and was originally proposed as a candidate tumour suppressor in this region [125, 126] . Expression of STIM1 is barely detectable in rhabdomyosarcoma tumours [126] . Tumour suppressor function is supported in studies showing that depletion of STIM1 expression transforms the weakly metastatic B16F0 mouse melanoma cell line into a more aggressive form, accelerating cell mobility in vitro and increasing metastasis in a mouse model of tumorigenesis [127] . STIM2 maps to chromosome 4p15.1, a region implicated in invasive carcinomas of the head and neck, breast and lung [128] [129] [130] .
Immune system
The importance of SOCE in immune function is underpinned by the identification of at least four families of patients with severe combined immunodeficiency (SCID) associated with a severe reduction in SOCE in T lymphocytes, B lymphocytes and fibroblasts
In resting T cells, NFAT normally resides in the cytoplasm in an inactive phosphorylated form, and T-cell receptor activation induces SOCE and activation of the serine/ threonine phosphatase calcineurin [69]. Calcineurin dephosphorylates NFAT and mediates its translocation into the nucleus where it exerts transcriptional regulation on the IL-2 promoter
Smooth muscle
Store-operated channels with similar characteristics to that of ICRAC have been described in various smooth muscle preparations, including vascular smooth muscle cells (VSMC) isolated from aorta [90, 91], portal vein [92] and pulmonary arteries [93], as well as smooth muscle cell (SMC) lines [94]. The detailed biophysical characteristics of SOCs in SMCs have recently been reviewed [95]. Much less is known about the regulation of these
An oncogenic rather than a tumour suppressive function has been demonstrated for STIM1 and STIM2 in glioblastoma multiforme, where both proteins have increased expression and/or increased copy number [131, 132] . The increased expression of both STIM1 and STIM2 in this tumour may correlate with the increased basal [Ca 2ϩ ]i and SOCE measured in primary cultures from glioblastoma tumours, and in glioblastoma cell lines compared with normal human astrocytes [133] , and potentially contribute to the highly malignant behaviour of this tumour type [131] .
An oncogenic role for STIM proteins is also implicated in other cancers. Overexpression of STIM1 increases the migration of MCF-10A cells, a non-tumorigenic mammary gland cell line which expresses moderate endogenous levels of STIM1 [134] . Conversely, siRNA-mediated depletion of STIM1 in the tumorigenic breast cancer cell line MDA-MB-231, which expresses higher levels of STIM1, reduces migratory capacity in vitro and dramatically decreases their ability to metastasize in vivo [134] . Fig. 3; M [141, 142] . In immune cells, Notch signalling can impose a regulatory phenotype on T cells [143] . Activating mutations in NOTCH1 are implicated in T-ALL/lymphoma, and are associated with increased activity of calcineurin/NFAT signalling [144] . It is interesting to note that glioblastoma multiforme is frequently associated with increased expression and activation of NOTCH1 and other members of this pathway [145, 146] , and is also associated with increased expression of STIM1 and STIM2 [131, 132] [147] .
Our own studies have demonstrated that overexpression of either STIM1 or STIM2 in rat PC12 pheochromocytoma cells does not affect the size of solid tumours formed after subcutaneous injection into nude mice, but causes significant invasion of cells into the body wall skeletal musculature, which was not evident after injection of parental PC12 cells (
C. elegans
The single C. elegans STIM orthologue, C-Stim, encodes a protein of similar size and structure to D-Stim [148] (Fig. 1) 
